Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTAFR | P25105 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14516040 | 0.99 | ACHE (0.33) | TDP1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL14516043 | 0.99 | ACHE (0.33) | TDP1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL760861 | 0.99 | ACHE (0.33) | TDP1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL14515982 | 0.96 | TDP1 (0.33) | TDP1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL762127 | 0.93 | PTAFR (0.33) | TDP1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL14516041 | 0.90 | PTGES (0.37) | — | |
| SCHEMBL760858 | 0.90 | ESR1 (0.35) | KDM4EALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL760842 | 0.90 | APP (0.43) | ALDH1A1CYP3A4MAPTCYP2C9CYP2C19 | |
| SCHEMBL762476 | 0.90 | ESR1 (0.36) | KDM4EALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6123583 | 0.90 | ACHE (0.39) | TDP1KDM4EALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8137823-B2 | Anthracene derivatives, process for preparation thereof, and organic electronic light emitting device using the same | LG CHEM, LTD. (KR) | 2012-03-20 | — | — | US | disclosed |
| US-20090079334-A1 | Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090079334-A1 | Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same | XPOT, ALAD, APRT | TDP1 2558/4885KDM4E 1716/4885ALDH1A1 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.